Literature DB >> 9347127

Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome.

D E Ross1, G K Thaker, R W Buchanan, B Kirkpatrick, A C Lahti, D Medoff, J J Bartko, J Goodman, A Tien.   

Abstract

The objective was to determine the relationships between eye tracking disorder (ETD) in schizophrenia, specific ocular motor measures, and the deficit syndrome. Twenty-five normal comparison subjects and 53 schizophrenic patients had eye movements tested with infrared oculography using a sinusoidal target. Patients were assessed with the Schedule for the Deficit Syndrome. For the patients, the distribution of position root mean square error (a global measure of pursuit) was best fit by a mixture of two normal distributions. This information was used to divide the patients into two subgroups, those with and those without ETD. ETD was almost completely accounted for by several specific ocular motor measures and was significantly associated with the deficit syndrome. The finding that ETD was almost completely accounted for by specific measures bridges a gap of interpretation in this field. ETD and the deficit syndrome of schizophrenia may share a common pathophysiology of cerebral cortical-subcortical circuits.

Entities:  

Mesh:

Year:  1997        PMID: 9347127     DOI: 10.1016/s0006-3223(96)00492-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia.

Authors:  Walter L Slaghuis
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

2.  Eye movement and visual motion perception in schizophrenia I: Apparent motion evoked smooth pursuit eye movement reveals a hidden dysfunction in smooth pursuit eye movement in schizophrenia.

Authors:  W L Slaghuis; A Hawkes; T Holthouse; R Bruno
Journal:  Exp Brain Res       Date:  2007-06-19       Impact factor: 1.972

3.  Seasonality of births in horizontal strabismus: comparison with birth seasonality in schizophrenia and other disease conditions.

Authors:  A B Agarwal; K Cassinelli; L A Johnson; K Matsuda; B Kirkpatrick; W Yang; C S von Bartheld
Journal:  J Dev Orig Health Dis       Date:  2019-03-22       Impact factor: 2.401

4.  Odor identification, eye tracking and deficit syndrome schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman; Raymond R Goetz; Jill Harkavy-Friedman; Cheryl Corcoran; Xavier Amador; Scott Yale; Jack M Gorman
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

5.  Smooth-pursuit eye movement and directional motion-contrast sensitivity in schizophrenia.

Authors:  Walter L Slaghuis; Alison C Bowling; Rebecca V French
Journal:  Exp Brain Res       Date:  2005-08-02       Impact factor: 1.972

6.  SPEM dysfunction and general schizotypy as measured by the SSQ: a controlled study.

Authors:  Dirk van Kampen; Jan Berend Deijen
Journal:  BMC Neurol       Date:  2009-06-29       Impact factor: 2.474

7.  Cognitive deficits in psychiatric disorders: Current status.

Authors:  J K Trivedi
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

8.  Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia.

Authors:  Margret S H Harris; Courtney L Wiseman; James L Reilly; Matcheri S Keshavan; John A Sweeney
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

9.  Attentional facilitation of response is impaired for antisaccades but not for saccades in patients with schizophrenia: implications for cortical dysfunction.

Authors:  Nikolaos Smyrnis; Ioannis A Malogiannis; Ioannis Evdokimidis; Nicholas C Stefanis; Christos Theleritis; Alexandros Vaidakis; Stavroula Theodoropoulou; Costas N Stefanis
Journal:  Exp Brain Res       Date:  2004-06-24       Impact factor: 1.972

10.  Deficit schizophrenia: Concept and validity.

Authors:  Sandeep Grover; Parmanand Kulhara
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.